Annual report pursuant to Section 13 and 15(d)

Geographic information - Major Customers (Details)

v3.22.4
Geographic information - Major Customers (Details) - Revenues - Customer Concentration Risk
12 Months Ended
Dec. 31, 2022
Astellas Pharma Inc.  
Major Customers  
Concentration risk (as a percentage) 21.00%
Genentech, Inc.  
Major Customers  
Concentration risk (as a percentage) 50.00%
GSK Collaboration And License Agreement  
Major Customers  
Concentration risk (as a percentage) 29.00%